The Role of Fibrin E on the Modulation of Endothelial Progenitors Adhesion, Differentiation and Angiogenic Growth Factor Production and the Promotion of Wound Healing Here researchers tested the importance of different extracellular matrices in regulating the angiogenic and wound healing potential of cord blood-derived endothelial progenitor cells. [Biomaterials] Family-Directed Umbilical Cord Blood Banking In order to provide a better service for families in need, directed-family cord blood banking activities should be encouraged and closely monitored with common standards and better information on current and future indications. [Haematologica] Neurogenic Properties and a Clinical Relevance of Multipotent Stem Cells Derived from Cord Blood Samples Stored in the Biobanks Here researchers have compared 5 major methods of blood processing: Sepax, Hetastarch, Plasma depletion, Prepacyte-SC and Density gradient. [Stem Cells Dev] MicroRNA and Messenger RNA Analyses of Mesenchymal Stem Cells Derived from Teeth and the Wharton Jelly of Umbilical Cord In this study, researchers integrated the use of microRNA and mRNA expression profiles to analyze human mesenchymal stem cells derived from Wharton’s jelly of the umbilical cord, milk teeth, and adult wisdom teeth. [Stem Cells Dev] Ultra High Yield Manufacture of Red Blood Cells from Hematopoietic Stem Cells Researchers successfully developed a robust ultra-high yield red blood cell (RBC) expansion process capable of producing over 500 units of RBC per umbilical cord blood donation using fully defined culture medium. [Tissue Eng Part C Methods] Reduced-Intensity Conditioning Hematopoietic SCT for Pediatric Patients with LAD-I: Clinical Efficacy and Importance of Chimerism This study attempts to show that reduced-intensity regimen leads to a favorable result in leukocyte adhesion deficiency type-I (LAD-I) patients even in those who have experienced comorbid complications. [Bone Marrow Transplant] Activated T Cells from Umbilical Cord Blood Armed with Anti-CD3 × Anti-CD20 Bispecific Antibody Mediate Specific Cytotoxicity Against CD20+ Targets with Minimal Allogeneic Reactivity: A Strategy for Providing Antitumor Effects After Cord Blood Transplants In this study, researchers asked whether anti-CD3–activated T cells (ATCs) from cord blood (CB) could be expanded and targeted to solid tumors or hematologic malignancies for infusions after unrelated CB stem cell transplant and whether cord blood ATCs could reduce alloresponsiveness. [Transfusion] Pharmacokinetics-Based Optimal Dose Prediction of Donor Source-Dependent Response to Mycophenolate Mofetil in Unrelated Hematopoietic Cell Transplantation Data from 36 unrelated allogeneic bone marrow and cord blood transplantations were analyzed retrospectively based on mycophenolic acid area under the curve (AUC0–24h). [Int J Hematol] |